The dont need to do Clinical Trials they already meet TGA/FDA guidelines.
The IP companies need to do the Clinical Trials like Zelira and Insomnia which is due tomorrow..
Then the Hard Cap can be used as the delivery method.
Interesting this announcement dropped before Insomnia!
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann Releases Low-dose Form Capsule
Ann: AusCann Releases Low-dose Form Capsule, page-7
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable